サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1375863

インターベンショナルカーディオロジーデバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report By Product (Coronary Stents, PTCA Balloon Catheters, Accessory Devices), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
インターベンショナルカーディオロジーデバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年10月04日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インターベンショナル心臓病学機器市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のインターベンショナルカーディオロジーデバイス市場規模は2030年までに223億5,000万米ドルに達する見込みです。

同市場は、2023年から2030年にかけてCAGR 7.2%で拡大する見込みです。冠動脈インターベンション手技に対する有利な償還政策、世界の心血管疾患（CVDs）および糖尿病の有病率の上昇、同市場における新製品ラインの発売などにより、インターベンショナル心臓病学機器に対する需要は増加傾向にあります。心血管疾患は、世界における死亡率および罹患率の主な原因の1つとなっています。冠動脈疾患と先天性心疾患は、世界中で流行している主要な心血管疾患です。

さらに、喫煙、座りっぱなしの生活、不適切な食事などの不健康なライフスタイルの採用が糖尿病の原因となっています。心臓カテーテル治療、血管形成術、経皮的冠動脈インターベンション（PCI）は、心血管疾患の治療に用いられる主要な手技のひとつです。糖尿病は心血管疾患を引き起こす主な原因の1つであるため、糖尿病患者の増加は予測期間中にインターベンショナル・カーディオロジー機器の需要を急増させると予想されます。市場は今後数年間で拡大すると予想されるが、特に保険適用が不十分な新興経済諸国では、医療機器の高価格が原因で成長が鈍化する可能性があります。

インターベンショナル・カーディオロジー市場レポート・ハイライト

  • 冠動脈ステント分野が2022年の売上高シェア64.6%で市場を独占。冠動脈ステント部門ではDESが売上の大半を占める
  • 分岐型ステントの開発や生分解性材料の使用など、冠動脈ステントの技術的進歩は、CVD治療の効率化と治療成績の向上につながっています。各社は製品開発やパートナーシップ、戦略的提携に積極的に取り組んでいます。前述の要因により、予測期間中の業界成長は促進されると予想されます。
  • アジア太平洋地域は予測期間中最も速いCAGR 7.9%で成長すると予想されます。この成長は、冠動脈疾患（CAD）の罹患率の増加やこの疾患のスクリーニング対策の改善など、いくつかの要因に起因しています。
  • 市場は複数の企業が存在するため断片化しています。このため、今後数年間は競合が激化すると予想されます。市場参入企業は、市場での存在感を高めるため、提携、販売・マーケティング活動、M&A、サービス拡大、統合提供、製品発売など、さまざまな戦略的イニシアティブを採用しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 インターベンション心臓病学デバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 心臓インターベンションデバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 心臓インターベンション装置市場：製品推定・動向分析

  • 心臓インターベンション装置市場：重要なポイント
  • 心臓インターベンション装置市場：製品動向と市場シェア分析、2022年および2030年
  • 冠状動脈ステント
  • PTCAバルーンカテーテル
  • アクセサリデバイス
  • 血管内イメージングカテーテルおよび圧力ガイドワイヤー

第5章 心臓インターベンション装置市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別心臓インターベンション装置市場：重要なポイント
  • 北米
    • 北米市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA市場推計・予測、2018年から2030年
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Abbott Laboratories
    • Medtronic
    • Boston Scientific
    • Spectranetics
    • Cardinal Health
    • Philips Healthcare
    • Terumo
    • Alvimedica
    • Teleflex Medical
    • B. Braun
    • Biosensors International
    • Meril Life Sciences
    • BIOTRONIK
    • ACIST Medical Systems
    • ASAHI INTECC
    • CID Vascular
    • Cook Medical
    • Medinol
    • Merit Medical Systems
    • NuMED
    • OpSens
    • Vascular Solutions
    • Zeon Medical
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India interventional cardiology devices market, by product, 2018 - 2030, (USD Million)
  • Table 21 Australia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa interventional cardiology devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE interventional cardiology devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait interventional cardiology devices market, by product, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Interventional cardiology devices: Market outlook
  • Fig. 9 Interventional cardiology devices: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Interventional cardiology devices market driver impact
  • Fig. 15 Interventional cardiology devices market restraint impact
  • Fig. 16 Interventional cardiology devices market strategic initiatives analysis
  • Fig. 17 Interventional cardiology devices market: Product movement analysis
  • Fig. 18 Interventional cardiology devices market: Product outlook and key takeaways
  • Fig. 19 Coronary stents market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 20 DES market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 BMS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BRS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 PTCA balloon catheters market estimates and forecasts, (USD million) 2018 - 2030
  • Fig. 24 Normal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Specialty market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 DCB market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Accessory devices market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 28 PTCA guidewires market estimates and forecasts, 2018 - 2030, (USD million)
  • Fig. 29 Diagnostic catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 PTCA guiding catheters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Introducer sheaths market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Intravascular imaging catheters and pressure guidewire market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global interventional cardiology devices market: Regional movement analysis
  • Fig. 34 Global interventional cardiology devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 -2030, (USD million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: 978-1-68038-122-1

Interventional Cardiology Devices Market Growth & Trends:

The global interventional cardiology devices market size is expected to reach USD 22.35 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.2% from 2023 to 2030 Demand for interventional cardiology devices is on the rise owing to favorable reimbursement policies for coronary intervention procedures, rising prevalence of cardiovascular diseases (CVDs) and diabetes across the globe, and the launch of new product lines in the market. Cardiovascular diseases have become one of the major causes of mortality and morbidity in the world. Coronary artery disease and congenital heart defects are the major cardiovascular diseases that are prevalent across the globe.

Furthermore, the adoption of unhealthy lifestyles, such as smoking, a sedentary lifestyle, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular diseases. Since diabetes is one of the major reasons behind triggering cardiovascular diseases, increasing diabetes cases are expected to surge the demand for interventional cardiology devices over the forecast period. Although the market is anticipated to expand over the coming years, it might witness slower growth possibly brought on by the high price of medical devices, especially in developing economies with insufficient insurance coverage.

Interventional Cardiology Devices Market Report Highlights:

  • The coronary stents segment dominated the market with the largest revenue share of 64.6% in 2022. DES makes up the majority of sales in the coronary stent category.
  • Technological advancements in coronary stents, such as the development of bifurcated stents and the use of biodegradable materials, have led to efficient and improved outcomes of CVD treatment. Companies are proactively involved in product developments and partnerships and strategic collaborations. The aforementioned factors are expected to propel industry growth over the forecast period
  • Asia Pacific region is expected to advance at the fastest CAGR of 7.9% over the forecast period. This growth can be attributed to several factors, including the increasing incidence of coronary artery disease (CAD) and improved screening measures for this disorder.
  • The market is fragmented due to the presence of several players. This is expected to intensify the competition in the coming years. Market players are adopting various strategic initiatives such as partnerships, sales & marketing activities, mergers & acquisitions, service expansion, integrated offerings, and product launches to increase their market presence

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Interventional Cardiology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Interventional Cardiology Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Interventional Cardiology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Interventional Cardiology Devices Market: Key Takeaways
  • 4.2. Interventional Cardiology Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Coronary Stents
    • 4.3.1. Coronary stents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. DES
      • 4.3.2.1. DES market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. BMS
      • 4.3.3.1. BMS market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. BRS
      • 4.3.4.1. BRS market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. PTCA Balloon Catheters
    • 4.4.1. PTCA balloon catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Normal
      • 4.4.2.1. Normal market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Specialty
      • 4.4.3.1. Specialty market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. DCB
      • 4.4.4.1. DCB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Accessory Devices
    • 4.5.1. Accessory devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. PTCA guidewires
      • 4.5.2.1. PTCA guidewires market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Diagnostic catheters
      • 4.5.3.1. Diagnostic catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. PTCA guiding catheters
      • 4.5.4.1. PTCA guiding catheters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Introducer sheaths
      • 4.5.5.1. Introducer sheaths market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Intravascular imaging catheters and pressure guidewires
    • 4.6.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Interventional Cardiology Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Interventional Cardiology Devices Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Abbott Laboratories
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Spectranetics
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Cardinal Health
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Philips Healthcare
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Terumo
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Alvimedica
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Teleflex Medical
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. B. Braun
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Biosensors International
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Meril Life Sciences
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. BIOTRONIK
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. ACIST Medical Systems
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. ASAHI INTECC
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives
    • 6.2.16. CID Vascular
      • 6.2.16.1. Company overview
      • 6.2.16.2. Financial performance
      • 6.2.16.3. Product benchmarking
      • 6.2.16.4. Strategic initiatives
    • 6.2.17. Cook Medical
      • 6.2.17.1. Company overview
      • 6.2.17.2. Financial performance
      • 6.2.17.3. Product benchmarking
      • 6.2.17.4. Strategic initiatives
    • 6.2.18. Medinol
      • 6.2.18.1. Company overview
      • 6.2.18.2. Financial performance
      • 6.2.18.3. Product benchmarking
      • 6.2.18.4. Strategic initiatives
    • 6.2.19. Merit Medical Systems
      • 6.2.19.1. Company overview
      • 6.2.19.2. Financial performance
      • 6.2.19.3. Product benchmarking
      • 6.2.19.4. Strategic initiatives
    • 6.2.20. NuMED
      • 6.2.20.1. Company overview
      • 6.2.20.2. Financial performance
      • 6.2.20.3. Product benchmarking
      • 6.2.20.4. Strategic initiatives
    • 6.2.21. OpSens
      • 6.2.21.1. Company overview
      • 6.2.21.2. Financial performance
      • 6.2.21.3. Product benchmarking
      • 6.2.21.4. Strategic initiatives
    • 6.2.22. Vascular Solutions
      • 6.2.22.1. Company overview
      • 6.2.22.2. Financial performance
      • 6.2.22.3. Product benchmarking
      • 6.2.22.4. Strategic initiatives
    • 6.2.23. Zeon Medical
      • 6.2.23.1. Company overview
      • 6.2.23.2. Financial performance
      • 6.2.23.3. Product benchmarking
      • 6.2.23.4. Strategic initiatives